These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 17559117)

  • 21. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
    Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
    J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linolenic acid-modified chitosan for formation of self-assembled nanoparticles.
    Liu CG; Desai KG; Chen XG; Park HJ
    J Agric Food Chem; 2005 Jan; 53(2):437-41. PubMed ID: 15656685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and evaluation of a nanoparticulate system prepared by biodegradable polymers for oral administration of protein drugs.
    Sahu SK; Prusty AK
    Pharmazie; 2010 Nov; 65(11):824-9. PubMed ID: 21155389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of bovine serum albumin with self-assembled nanoparticles of 6-O-cholesterol modified chitosan.
    Li X; Chen M; Yang W; Zhou Z; Liu L; Zhang Q
    Colloids Surf B Biointerfaces; 2012 Apr; 92():136-41. PubMed ID: 22178440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
    Lin CC; Lin CW
    Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
    Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
    Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monodisperse chitosan nanoparticles for mucosal drug delivery.
    Zhang H; Oh M; Allen C; Kumacheva E
    Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan.
    Boddohi S; Moore N; Johnson PA; Kipper MJ
    Biomacromolecules; 2009 Jun; 10(6):1402-9. PubMed ID: 19371056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microstructure formation and property of chitosan-poly(acrylic acid) nanoparticles prepared by macromolecular complex.
    Chen Q; Hu Y; Chen Y; Jiang X; Yang Y
    Macromol Biosci; 2005 Oct; 5(10):993-1000. PubMed ID: 16211548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of polyelectrolyte structure on protein-polyelectrolyte coacervates: coacervates of bovine serum albumin with poly(diallyldimethylammonium chloride) versus chitosan.
    Kayitmazer AB; Strand SP; Tribet C; Jaeger W; Dubin PL
    Biomacromolecules; 2007 Nov; 8(11):3568-77. PubMed ID: 17892297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE
    Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
    Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
    Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterisation of chitosan nanoparticles for siRNA delivery.
    Katas H; Alpar HO
    J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
    Tiyaboonchai W; Limpeanchob N
    Int J Pharm; 2007 Feb; 329(1-2):142-9. PubMed ID: 17000065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
    Shahbazi MA; Hamidi M; Mohammadi-Samani S
    J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of new insulin containing polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D
    Colloids Surf B Biointerfaces; 2006 Dec; 53(2):193-202. PubMed ID: 17049214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and antioxidant activity of Elsholtzia splendens extract-loaded nanoparticles.
    Lee JS; Kim GH; Lee HG
    J Agric Food Chem; 2010 Mar; 58(6):3316-21. PubMed ID: 20187637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.